{
    "Trade/Device Name(s)": [
        "FIRST RESPONSE\u2122 Early Result Pregnancy Test"
    ],
    "Submitter Information": "Church & Dwight Co., Inc.",
    "510(k) Number": "K123436",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083716"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "August 26, 2013",
    "Summary Letter Received Date": "August 8, 2013",
    "Submission Date": "July 30, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (hCG) test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)",
        "hCG beta core fragment (hCG \u03b2cf)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for FIRST RESPONSE\u2122 Early Result Pregnancy Test, a qualitative chromatographic immunoassay for early detection of hCG in urine.",
    "Indications for Use Summary": "Over-the-counter chromatographic immunoassay for qualitative detection of hCG in urine as an aid in early pregnancy detection, in some cases as early as six days before missed period.",
    "fda_folder": "Clinical Chemistry"
}